NZ Breast Cancer Research Review Issue 34

In this issue:
  -  Endocrine therapy for male breast cancer
  -  Mindfulness-based interventions
  -  Menopausal symptoms, sexual problems, and mood disturbances
  -  Introducing SentiMag in a rural setting
  -  Margin width and local recurrence after neoadjuvant chemotherapy
  -  Duration of adjuvant aromatase inhibitor therapy
  -  Real time remote symptom monitoring
  -  Adjuvant olaparib for patients with BRCA1/2 mutations
  -  Adjuvant pertuzumab and trastuzumab in early HER2+ breast cancer
  -  Niraparib for aBC with germline BRCA1/2 mutations

Please login below to download this issue (PDF)